Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Total 13F shares
-
209,062,727
-
Share change
-
-1,417,041
-
Total reported value
-
$23,789,457,142
-
Put/Call ratio
-
153%
-
Price per share
-
$113.80
-
Number of holders
-
599
-
Value change
-
+$339,626,925
-
Number of buys
-
295
-
Number of sells
-
323
Institutional Holders of HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) as of Q4 2022
As of 31 Dec 2022,
HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) was held by
599 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
209,062,727 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, Capital International Investors, Avoro Capital Advisors LLC, STATE STREET CORP, Nuveen Asset Management, LLC, HBK INVESTMENTS L P, T. Rowe Price Investment Management, Inc., and JANUS HENDERSON GROUP PLC.
This page lists
599
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.